Panchsheel Organics Ltd
BSE:531726
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nishimatsuya Chain Co Ltd
TSE:7545
|
JP |
|
G
|
Genting Bhd
OTC:GEBHF
|
MY |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IN |
P
|
Panchsheel Organics Ltd
BSE:531726
|
1.5B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563.9B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.5B GBP |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.1B USD |
Loading...
|
Market Distribution
| Min | -3 052.3% |
| 30th Percentile | 26.9% |
| Median | 39% |
| 70th Percentile | 53.3% |
| Max | 8 269.1% |
Other Profitability Ratios
Panchsheel Organics Ltd
Glance View
Panchsheel Organics Ltd. engages in the manufacture of pharmaceuticals and medicinal chemical products. The company is headquartered in Mumbai, Maharashtra. The firm's products include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression, fitness and healthcare products, and product development and testing laboratory. The firm offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone and Leflunomide. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and drosperinone. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder and Phytosterol.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Panchsheel Organics Ltd is 34%, which is below its 3-year median of 34.5%.
Over the last 3 years, Panchsheel Organics Ltd’s Gross Margin has decreased from 39.7% to 34%. During this period, it reached a low of 32.6% on Jun 30, 2024 and a high of 39.7% on Dec 31, 2022.
